StockData
Lisata Therapeutics, Inc. logo

Lisata Therapeutics, Inc. (LSTA) stock

LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.04−0.05 (-4.59%)

Close on Nov 17, 2026Market cap $9.37MP/E –Yield –

Lisata Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

Lisata Therapeutics's gross margin for the twelve months ending Mar 31, 2017 was 7.7%. For fiscal 2016 it was 11.8%, against 10.4% the year before. The highest annual figure on record is 28.9% in fiscal 2010.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2016Dec 31, 201611.8%+1.4
FY2015Dec 31, 201510.4%−2.2
FY2014Dec 31, 201412.6%+0.9
FY2013Dec 31, 201311.7%−4.9
FY2012Dec 31, 201216.6%+2.6
FY2011Dec 31, 201114.0%−14.9
FY2010Dec 31, 201028.9%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2017Mar 31, 2017-1.5%–
Q4 FY2016Dec 31, 20169.2%–
Q3 FY2016Sep 30, 20167.6%–

More Lisata Therapeutics figures

See a number that looks wrong?